Joint Commission proposes changes to patient suicide risk policies

The Joint Commission has begun accepting comments on proposed revisions to National Patient Safety Goal (NPSG) requirements to “better identify and care” for patients who may be at risk of attempting suicide.

The changes would affect three Joint Commission accreditation programs covering hospitals, critical access hospitals and behavioral healthcare.

In all three care settings, the revised standards say facilities should be able to recognize risk factors in patients, because not all patients will voluntarily disclose suicide ideation. A simple screening tool should be used, along with a more in-depth assessment to identify imminent risks, and all facilities should have plans on what to do with at-risk patients.

“Depending on the acuity of the suicide risk, it could involve taking care of the patient within the organization, transferring the individual to another healthcare setting, referring the patient to another provider of care or other external resources,” the proposed guidelines said.

The elements of performance will be the same across all three care settings:

  1. Use an evidence-based tool to screen patients being treated for behavioral or emotional disorders. Examples of tools include Emergency Medicine Network’s ED-SAFE Patient Safety Screener for emergency departments and the Suicide Behaviors Questionnaire-Revised (SBQ-R).
  2. When a patient has been positively screened for suicide risk, conduct an assessment using evidence-based tools or refer the patient to another provider for such an assessment.
  3. Implement policies and procedures addressing the care of individuals identified as at risk for suicide. The proposed changes note that policies and procedure should be consistent with the needs of patients and organizational resources, and may include “a safe environment, notifying family members or friends as appropriate, transferring the individual to another provider (including logistics), providing referrals to resources such as crisis hot lines and counseling, and developing individual safety plans."
  4. Monitor implementation of policies and procedures on the care of individuals identified as suicidal or at risk for suicide and take action as needed to improve compliance.

Comments on the requirements for all three accreditation programs will be accepted through May 1. 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.